Package 61958-0705-1

{"route": ["ORAL"], "spl_id": "32422ee8-1cdc-4305-bb3e-0458472513fc", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "unii": ["OTT9J7900I", "G70B4ETF4S"], "rxcui": ["476556", "639888", "1744001", "1744003", "1744005", "1744007", "1744009", "1744011"], "spl_set_id": ["54e82b13-a037-49ed-b4b3-030b37c0ecdd"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Gilead Sciences, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-0705-1)", "package_ndc": "61958-0705-1", "marketing_start_date": "20160310"}], "brand_name": "Truvada", "product_id": "61958-0705_32422ee8-1cdc-4305-bb3e-0458472513fc", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "61958-0705", "generic_name": "emtricitabine and tenofovir disoproxil fumarate", "labeler_name": "Gilead Sciences, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Truvada", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "167 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "250 mg/1"}], "application_number": "NDA021752", "marketing_category": "NDA", "marketing_start_date": "20160310", "listing_expiration_date": "20261231"}